|
Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer |
Mitera G, Swaminath A, Rudoler D, Seereeram C, Giuliani M, Leighl N, Gutierrez E, Dobrow MJ, Coyte PC, Yung T, Bezjak A, Hope AJ |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Mitera G, Swaminath A, Rudoler D, Seereeram C, Giuliani M, Leighl N, Gutierrez E, Dobrow MJ, Coyte PC, Yung T, Bezjak A, Hope AJ. Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer. Journal of Oncology Practice 2014; 10(3): e130-e136 Indexing Status Subject indexing assigned by NLM MeSH Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung /economics /mortality /pathology /radiotherapy; Cost-Benefit Analysis; Dose Fractionation; Female; Humans; Lung Neoplasms /economics /mortality /pathology /radiotherapy; Male; Middle Aged; Neoplasm Staging AccessionNumber 22014014211 Date bibliographic record published 28/08/2014 |
|
|
|